The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 10, 2020

Filed:

Dec. 11, 2017
Applicant:

The Regents of the University of California, Oakland, CA (US);

Inventors:

Kazuhiro Aoyagi, Miyagi, JP;

Michael Zakrewsky, San Diego, CA (US);

Samir Mitragotri, Lexington, MA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/70 (2006.01); A61K 9/00 (2006.01); A61K 31/138 (2006.01); A61K 31/194 (2006.01); A61P 35/00 (2006.01); A61K 47/12 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 47/10 (2017.01); A61K 47/20 (2006.01);
U.S. Cl.
CPC ...
A61K 9/7038 (2013.01); A61K 9/0014 (2013.01); A61K 9/0095 (2013.01); A61K 31/138 (2013.01); A61K 31/194 (2013.01); A61K 47/10 (2013.01); A61K 47/12 (2013.01); A61K 47/20 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61P 35/00 (2018.01);
Abstract

Melts or ionic liquids containing amorphous propranolol, topical formulations and patches for transdermal drug delivery, and methods of making and using thereof are described herein. The melts or ionic liquids may be in a topical drug delivery formulation or patch to be applied to the skin. The drug delivery formulation or patch contains a sufficient amount of the amorphous propranolol to deliver a therapeutically effective amount of the amorphous propranolol to the patient in need of treatment, such as for the treatment or amelioration of infantile hemangioma. The formulations have a low viscosity and reduced skin irritation compared to the crystalline propranolol free base (PFB). The melts or ionic liquids can be formed by a salt metathesis reaction.


Find Patent Forward Citations

Loading…